- Home
- MIST vs EAD Comparison
MIST vs EAD Comparison
Compare MIST & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- EAD
- Stock Information
- Founded
- MIST 2003
- EAD 2003
- Country
- MIST Canada
- EAD United States
- Employees
- MIST N/A
- EAD N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- MIST Health Care
- EAD Finance
- Exchange
- MIST Nasdaq
- EAD Nasdaq
- Market Cap
- MIST 53.9M
- EAD N/A
- IPO Year
- MIST N/A
- EAD N/A
- Fundamental
- Price
- MIST $1.24
- EAD $6.72
- Analyst Decision
- MIST Strong Buy
- EAD
- Analyst Count
- MIST 2
- EAD 0
- Target Price
- MIST $9.50
- EAD N/A
- AVG Volume (30 Days)
- MIST 2.0M
- EAD 178.9K
- Earning Date
- MIST 05-12-2025
- EAD 01-01-0001
- Dividend Yield
- MIST N/A
- EAD 8.91%
- EPS Growth
- MIST N/A
- EAD N/A
- EPS
- MIST N/A
- EAD N/A
- Revenue
- MIST N/A
- EAD N/A
- Revenue This Year
- MIST N/A
- EAD N/A
- Revenue Next Year
- MIST N/A
- EAD N/A
- P/E Ratio
- MIST N/A
- EAD N/A
- Revenue Growth
- MIST N/A
- EAD N/A
- 52 Week Low
- MIST $0.63
- EAD $5.69
- 52 Week High
- MIST $2.75
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- MIST 53.98
- EAD 56.22
- Support Level
- MIST $1.09
- EAD $6.38
- Resistance Level
- MIST $1.37
- EAD $6.67
- Average True Range (ATR)
- MIST 0.10
- EAD 0.11
- MACD
- MIST 0.10
- EAD 0.05
- Stochastic Oscillator
- MIST 89.28
- EAD 100.00
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).